SCHEMBL4335786

SCHEMBL4335786

COc1c(NC(=O)C2CC2)ccc2[nH]nc(-c3cc4ccccc4s3)c12

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 1/20 0.52
TNIK Q9UKE5 5/20 0.43
SIRT2 Q8IXJ6 1/20 0.42
SIRT1 Q96EB6 1/20 0.42
ITK Q08881 2/20 0.40
HTT P42858 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ATM Q13315 1/20 0.40
PDPK1 O15530 1/20 0.39
NTRK1 P04629 1/20 0.39
FLT3 P36888 1/20 0.39
NTRK3 Q16288 1/20 0.39
NTRK2 Q16620 1/20 0.39
PIP5K1C O60331 1/20 0.39
MAPKAPK2 P49137 1/20 0.39
JAK2 O60674 2/20 0.38
ALDH1A1 P00352 1/20 0.38
MAP4K1 Q92918 1/20 0.37
SLC6A3 Q01959 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2867309 0.88 TNIK (0.44) MAPK10TNIKSIRT2SIRT1ITK
SCHEMBL4340656 0.87 MAPK10 (0.44) MAPK10TNIKSIRT2SIRT1HTT
SCHEMBL4345589 0.87 MAPK10 (0.44) MAPK10TNIKSIRT2SIRT1HTT
SCHEMBL4343158 0.86 MAPK10 (0.54) MAPK10TNIKSIRT2SIRT1ITK
SCHEMBL2867192 0.83 TNIK (0.41) MAPK10TNIKSIRT2SIRT1ITK
SCHEMBL4335978 0.82 GSK3B (0.47) ITKHTTPDPK1JAK2ALDH1A1
SCHEMBL2865310 0.82 TNIK (0.40) MAPK10TNIKSIRT2SIRT1ITK
SCHEMBL4337647 0.82 STK33 (0.44) MAPK10TNIKKDM4EALDH1A1
SCHEMBL13635758 0.81 MAPK10 (0.40) MAPK10TNIKSIRT2SIRT1ITK
SCHEMBL4342242 0.81 HSD17B10 (0.43) MAPK10TNIKITKHTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAPK10 29/4885TNIK 1243/4885SIRT2 1519/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAPK10 29/4885TNIK 1243/4885SIRT2 1519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.